文献速递肝胆胰外科胃肠外科

肝胰十二指肠切除术治疗胆道癌:近零手术死亡率的策略与可接受的长期结局

Hepatopancreaticoduodenectomy for Biliary Cancer: Strategies for Near-zero Operative Mortality and Acceptable Long-term Outcome.
PubMed 文献 · Ann Surg · 2018-01-01

结果显示90天死亡率为0,5年总生存率44.5%,胆管癌与胆囊癌患者间无显著差异。基于术中发现的13例改行HPD者无复发生存率较差(P=0.004)。

要点

  • HPD在严格策略下可安全实施,90天死亡率为0。
  • 5年总生存率44.5%,胆管癌与胆囊癌无显著差异。
  • 术中改行HPD者无复发生存率较差(P=0.004)。

核心结论

  • HPD采用所报告的手术策略可安全实施,短期和长期结局可接受。
  • 精确评估肿瘤播散范围可能改善患者结局。

主要发现

  • 90天死亡率为0;1例患者于术后230天死于肝脓肿。
  • 术后严重并发症(III级及以上)19例(37%),肝功能不全2例(3.8%)。
  • 未发生胰瘘形成后的腹腔出血事件。
  • 5年总生存率为44.5%,胆管癌与胆囊癌患者间无显著差异。
  • 13例基于术中发现改行HPD,其无复发生存率较未改行手术者差(P=0.004)。

关键数值与推荐

  • 所有行右侧HPD或左三肝切除的患者均接受术前胆道引流和门静脉栓塞。
  • 42例患者行大范围肝切除,所有病例均选择二期胰肠吻合。

临床怎么用

  • 对于广泛胆管癌及部分晚期胆囊癌,HPD可在严格策略下安全实施。
  • 术前胆道引流和门静脉栓塞、二期胰肠吻合等策略可能有助于降低死亡率。
  • 术中精确评估肿瘤播散范围,避免不必要的改行HPD。

局限性

  • 单中心经验,结果需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The purpose of this study was to evaluate the safety and efficacy of hepatopancreaticoduodenectomy (HPD) for patients with biliary cancer. BACKGROUND: HPD is thought to be the only curative treatment for widespread bile duct cancer and for some advanced cases of gallbladder cancer; however, HPD has not yet been accepted as a standard operative procedure because of concerns over morbidity and mortality. METHODS: Fifty-two patients undergoing HPD were retrospectively reviewed. The patient and tumor characteristics, preoperative treatments, operative results, and survival outcomes were investigated. RESULTS: Preoperative biliary drainage and portal vein embolization were applied for all patients undergoing right-sided HPD or a left trisectionectomy. A major hepatectomy was performed in 42 patients, and a 2-stage pancreaticojejunostomy was selected in all the cases. The 90-day mortality was 0; however, 1 patient died because of a liver abscess 230 days after surgery. Postoperative significant complications (grade III or greater) and liver insufficiency were observed in 19 (37%) and 2 (3.8%) patients, respectively, and no abdominal bleeding events after the formation of a pancreatic fistula were encountered. The 5-year overall survival rate was 44.5%, and a significant difference was not observed between patients with bile duct cancer and those with gallbladder cancer. The operative procedure was switched to an HPD in 13 patients based on intraoperative findings, and the recurrence-free survival rate for these patients was poorer than that for patients who did not require a switch in operative procedure (P = 0.004). CONCLUSIONS: HPD can be safely performed using the presently reported surgical strategies with acceptable short and long-term outcomes. A precise assessment of the extent of tumor spread might improve patient outcome.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Aoki T, Sakamoto Y, Kohno Y, et al. Hepatopancreaticoduodenectomy for Biliary Cancer: Strategies for Near-zero Operative Mortality and Acceptable Long-term Outcome. Ann Surg. 2018. PMID: 27811506. doi:10.1097/SLA.0000000000002059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。